Jointown Pharmaceutical shareholder redeems exchangeable bonds

On October 10, 2025, Jointown Pharmaceutical Group announced that its controlling shareholder, Chuchang Investment Group Co., Ltd., has fully redeemed and delisted its "Chuchang Investment Group Co., Ltd. 2022 Non-Public Issuance Exchangeable Corporate Bonds (Tranche 1)."

Following this, Chuchang Investment Group will apply to China Securities Depository and Clearing Corporation Limited Shanghai Branch to cancel the associated stock pledges and trust registrations. These were initially disclosed on August 31, 2022.

Upon the redemption and delisting, Chuchang Investment Group and China Merchants Securities will request the transfer of 17,587,759 shares of the company, previously held in a pledge and trust account, back to Chuchang Investment Group's securities account. As of October 9, 2025, Chuchang Investment Group held 362,525,962 shares directly, representing 7.19% of the company's shares, with the pledged shares accounting for 0.35%.

After the cancellation of the pledges and trust registrations, Chuchang Investment Group's direct holdings will increase to 380,113,721 shares, representing 7.54% of Jointown Pharmaceutical Group's total shares (excluding other exchangeable bond pledge and trust accounts). This transaction will not alter the company's controlling shareholder or actual controller and does not constitute a tender offer.